documents: FDA-2017-D-5767-0021

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-D-5767-0021 FDA FDA-2017-D-5767 Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of Recombinant Deoxyribonucleic Acid Origin; Draft Guidance for Industry; Availability; Extension of Comment Period Notice Notice of Availability 2017-12-08T05:00:00Z 2017 12 2017-12-08T05:00:00Z 2018-02-05T04:59:59Z 2018-02-03T02:04:56Z 2017-26436 0 0 0900006482cf2a7a

Links from other tables